François Ghiringhelli
Full Professor(heuristic)
Cancer Immunotherapy and Biomarkers · Oncology
Compare more Oncology professors.
h-index108
i10-index361
Publications976
Citations59,534
Grants
No NSF/NIH grants on record.
Recent Public Signals
- New paper: Supplementary Figure S2 from The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer2026-07-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0002-5465-8305